Veru (VERU) Current Assets (2010 - 2026)
Veru (VERU) posted quarterly Current Assets of $33.4 million for Q1 2026, up 56.03% year-over-year from $21.4 million in Q1 2025, and down 9.38% quarter-over-quarter from $36.8 million in Q4 2025.
Veru (VERU) Current Assets (2010 - 2026) Analysis & Trends
Veru (VERU) has reported Current Assets for 17 consecutive years, with $33.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 56.03% year-over-year to $33.4 million; the TTM figure through Mar 2026 stood at $33.4 million (up 56.03% YoY), while the FY2025 annual figure was $18.9 million, down 46.3% from the prior year.
- Current Assets declined to $33.4 million in Q1 2026 per VERU's latest filing, from $36.8 million in the prior quarter.
- Across five years, Current Assets topped out at $140.5 million in Q1 2022 and bottomed at $16.2 million in Q2 2025.
- Historically, Current Assets has averaged $51.1 million across 5 years, with a median of $36.8 million in 2025.
- Annual changes were most pronounced in 2023 — Current Assets plunged 77.95% — and 2026, when it surged 56.03%.
- Veru's Current Assets stood at $70.5 million in 2022, then decreased by 24.33% to $53.3 million in 2023, then plunged by 46.8% to $28.4 million in 2024, then gained by 29.69% to $36.8 million in 2025, then decreased by 9.38% to $33.4 million in 2026.
- Business Quant data shows VERU's Current Assets at $33.4 million in Q1 2026, $36.8 million in Q4 2025, and $18.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Veru | 59.70 Mn | 33.91 Mn | - | 27.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.23 Mn |
| Mar 31, 2026 | 33.36 Mn |
| Dec 31, 2025 | 36.81 Mn |
| Sep 30, 2025 | 18.92 Mn |
| Jun 30, 2025 | 16.19 Mn |
| Mar 31, 2025 | 21.38 Mn |
| Dec 31, 2024 | 28.38 Mn |
| Sep 30, 2024 | 35.22 Mn |
| Jun 30, 2024 | 38.48 Mn |
| Mar 31, 2024 | 45.14 Mn |
| Dec 31, 2023 | 53.34 Mn |
| Sep 30, 2023 | 22.93 Mn |
| Jun 30, 2023 | 32.67 Mn |
| Mar 31, 2023 | 43.37 Mn |
| Dec 31, 2022 | 70.50 Mn |
| Sep 30, 2022 | 104.00 Mn |
| Jun 30, 2022 | 128.36 Mn |
| Mar 31, 2022 | 140.46 Mn |
| Dec 31, 2021 | 145.71 Mn |
| Sep 30, 2021 | 151.75 Mn |